Latest News

Dr. Stephanie Kennedy is co-author on three posters regarding risk assessment strategies for microplastics and is looking forward to attending scientific platform and poster sessions across environmental topics.  Featured Presentations: (employees will be linked to website profile page) Scott Coffin, Andrew Barrick, Andrew Yeh, Anna Tuulikki Kukkola, Bethanie Carney Almroth, Ezra L Miller, Kazi Towsif Ahmed, Lidwina Bertrand, Mariella Sina, Luan de Sourz Leite, Magdalena M. Mair, Stephanie B Kennedy, Tham C. Hoang Win Cowger – read more…

BlueRidge Life Sciences is at the annual meeting of ISPOR (The Professional Society for Health Economics and Outcomes Research), held this year in Montreal May 13–16, 2025. Our BlueRidge Life Sciences Pharmaceutical Commercialization team brings expertise in HEOR, and other commercialization services and works with clients to craft strategies that effectively communicate the value of their therapies. Reach out here to set up a meeting with one of our HEOR experts! #BlueRidgeLifeSciences #ISPORAnnual

BlueRidge Life Sciences Pharmaceutical Commercialization’s Dr. Naomi Sacks’s work published in Obesity Science & Practice on behalf of The Obesity Society was recently ranked within the top 10% of most-viewed papers published by the journal in 2023. In their study, Dr. Sacks and colleagues used national survey data to examine clinical, economic, and health-related quality-of-life outcomes associated with being overweight and obesity. They found evidence that being overweight and obesity are significantly associated with obesity-related read more…

ToxStrategies and EpidStrategies are pleased to announce the promotion of 12 of our scientists, epidemiologists and engineers. We are proud to have them on our team! Click the image below for profile links.  

Dr. William Rish, ToxStrategies’ Principal Engineer, was invited to present to an ad hoc committee assembled by the National Academies of Sciences, Engineering, and Medicine (NASEM) that convened state of the science workshops and is developing a consensus report to advise the U.S. Environmental Protection Agency (EPA) on developing the scientific foundation for cumulative impact assessment (CIA). CIA can help scientists and communities understand the impacts of environmental stressors on vulnerable groups and provide a read more…

ToxStrategies scientists John Rogers, Melissa Heintz, Chad Thompson, and Laurie Haws were recently notified that their paper A putative adverse outcome network for neonatal mortality and lower birth weight in rodents: Applicability to per- and polyfluoroalkyl substances and relevance to human health, which was published in Birth Defects Research, was named one of the journal’s top 10 most-cited papers published in 2023. Congratulations to the authors!